US Stock MarketDetailed Quotes

ONCY Oncolytics Biotech

Watchlist
  • 0.820
  • -0.067-7.60%
Trading Dec 20 13:53 ET
63.20MMarket Cap-3.28P/E (TTM)

Oncolytics Biotech Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(Q3)Sep 30, 2024
(FY)Dec 31, 2023
(Q4)Dec 31, 2023
(Q3)Sep 30, 2023
(Q2)Jun 30, 2023
(Q1)Mar 31, 2023
(FY)Dec 31, 2022
(Q4)Dec 31, 2022
(Q3)Sep 30, 2022
(Q2)Jun 30, 2022
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities
19.87%-4.83M
-21.81%-28.45M
-3.12%-6.12M
-41.98%-6.03M
-22.38%-8.47M
-25.22%-7.83M
-4.11%-23.36M
6.25%-5.94M
-13.77%-4.25M
-1.77%-6.92M
Net income from continuing operations
3.85%-9.54M
-11.75%-27.75M
53.83%-3.95M
-125.16%-9.93M
-46.05%-7.44M
5.04%-6.44M
5.58%-24.84M
-10.36%-8.55M
9.53%-4.41M
29.69%-5.09M
Operating gains losses
72.14%-197K
-211.71%-5M
-6,943.28%-4.59M
44.33%-707K
153.87%444K
-136.64%-155K
-492.42%-1.61M
-77.42%67K
-5.36%-1.27M
-230.07%-824.14K
Depreciation and amortization
1.94%105K
2.81%403K
8.08%107K
6.19%103K
-1.65%96K
-1.02%97K
-13.27%392K
2.16%99K
14.76%97K
-40.42%97.61K
Other non cash items
-43.24%42K
193.42%71K
112.86%18K
289.47%74K
251.67%75K
-500.00%-96K
-182.61%-76K
-635.33%-140K
-31.13%19K
-12.77%21.33K
Change In working capital
17.44%4.32M
351.41%1.77M
-17.07%1.53M
350.92%3.68M
-17.03%-1.88M
-136.68%-1.56M
143.06%391K
1,492.02%1.84M
-33.50%815K
-14.41%-1.61M
-Change in receivables
----
46.67%506K
----
----
----
-127.36%-209K
144.46%345K
96.09%-24K
----
-947.41%-253.39K
-Change in prepaid assets
----
162.31%777K
----
----
----
94.47%-65K
-257.31%-1.25M
176.77%1.32M
----
12.93%-1.41M
-Change in payables and accrued expense
----
-104.69%-78K
----
----
----
-2,424.59%-1.42M
808.20%1.66M
195.02%329K
----
-51.39%133.85K
-Change in other current liabilities
----
194.32%332K
----
----
----
--0
-254.39%-352K
--0
----
--0
-Change in other working capital
----
1,441.18%228K
----
----
----
204.44%137K
91.24%-17K
10,881.81%211K
----
-122.20%-75.5K
Cash from discontinued investing activities
Operating cash flow
19.87%-4.83M
-21.81%-28.45M
-3.12%-6.12M
-41.98%-6.03M
-22.38%-8.47M
-25.22%-7.83M
-4.11%-23.36M
6.25%-5.94M
-13.77%-4.25M
-1.77%-6.92M
Investing cash flow
Cash flow from continuing investing activities
-100.47%-32K
199.11%20.22M
99.99%-3K
75,277.78%6.77M
58,408.29%6.79M
18,625.00%6.67M
-7,033.92%-20.4M
-27,114.97%-20.35M
95.60%-9K
-76.49%-11.65K
Net PPE purchase and sale
---32K
85.45%-8K
-400.00%-3K
--0
--0
86.11%-5K
80.77%-55K
101.34%1K
95.60%-9K
-76.49%-11.65K
Net investment purchase and sale
--0
199.42%20.23M
--0
--6.77M
--6.79M
--6.67M
---20.35M
---20.35M
--0
----
Cash from discontinued investing activities
Investing cash flow
-100.47%-32K
199.11%20.22M
99.99%-3K
75,277.78%6.77M
58,408.29%6.79M
18,625.00%6.67M
-7,033.92%-20.4M
-27,114.97%-20.35M
95.60%-9K
-76.49%-11.65K
Financing cash flow
Cash flow from continuing financing activities
-100.81%-173K
162.14%31.99M
-70.32%1.74M
1,727.38%21.29M
2,262.59%3.69M
5.13%5.27M
-63.03%12.21M
11,305.07%5.87M
1,562.28%1.17M
-98.04%156.27K
Net issuance payments of debt
21.57%-80K
-6.82%-407K
-1.96%-104K
-6.25%-102K
-6.76%-100K
-13.48%-101K
-4.10%-381K
-26.71%-102K
-27.53%-96K
4.96%-93.67K
Net common stock issuance
-100.74%-158K
151.47%31.62M
-75.37%1.47M
1,591.36%21.33M
1,279.95%3.45M
5.52%5.37M
-61.80%12.57M
66,507.21%5.97M
13,761.97%1.26M
-96.90%249.94K
Proceeds from stock option exercised by employees
3.17%65K
6,408.33%781K
--375K
--63K
----
----
-97.44%12K
--0
--0
--0
Cash from discontinued financing activities
Financing cash flow
-100.81%-173K
162.14%31.99M
-70.32%1.74M
1,727.38%21.29M
2,262.59%3.69M
5.13%5.27M
-63.03%12.21M
11,305.07%5.87M
1,562.28%1.17M
-98.04%156.27K
Net cash flow
Beginning cash position
41.84%24.85M
-71.73%11.67M
23.54%39.98M
-47.99%17.52M
-59.80%15.87M
-71.73%11.67M
32.17%41.26M
-32.70%32.36M
-33.68%33.69M
-21.60%39.48M
Current changes in cash
-122.87%-5.04M
175.33%23.77M
78.52%-4.39M
812.55%22.03M
129.78%2.02M
422.68%4.11M
-406.46%-31.55M
-215.95%-20.42M
23.06%-3.09M
-675.27%-6.77M
Effect of exchange rate changes
-149.31%-215K
-126.67%-522K
-144.29%-684K
-75.28%436K
-137.70%-369K
118.81%95K
870.47%1.96M
23.07%-280K
35.15%1.76M
232.27%978.82K
End cash Position
-50.98%19.6M
199.26%34.91M
199.26%34.91M
23.54%39.98M
-48.00%17.52M
-59.80%15.87M
-71.73%11.67M
-71.73%11.67M
-32.70%32.36M
-33.68%33.69M
Free cash flow
19.34%-4.86M
-21.55%-28.46M
-3.18%-6.13M
-41.68%-6.03M
-22.17%-8.47M
-24.59%-7.83M
-3.04%-23.41M
7.36%-5.94M
-8.09%-4.26M
-1.84%-6.93M
Currency Unit
CAD
CAD
CAD
CAD
CAD
CAD
CAD
CAD
CAD
CAD
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
--
Unqualified Opinion
--
--
--
--
Unqualified Opinion
--
--
--
(Q3)Sep 30, 2024(FY)Dec 31, 2023(Q4)Dec 31, 2023(Q3)Sep 30, 2023(Q2)Jun 30, 2023(Q1)Mar 31, 2023(FY)Dec 31, 2022(Q4)Dec 31, 2022(Q3)Sep 30, 2022(Q2)Jun 30, 2022
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities 19.87%-4.83M-21.81%-28.45M-3.12%-6.12M-41.98%-6.03M-22.38%-8.47M-25.22%-7.83M-4.11%-23.36M6.25%-5.94M-13.77%-4.25M-1.77%-6.92M
Net income from continuing operations 3.85%-9.54M-11.75%-27.75M53.83%-3.95M-125.16%-9.93M-46.05%-7.44M5.04%-6.44M5.58%-24.84M-10.36%-8.55M9.53%-4.41M29.69%-5.09M
Operating gains losses 72.14%-197K-211.71%-5M-6,943.28%-4.59M44.33%-707K153.87%444K-136.64%-155K-492.42%-1.61M-77.42%67K-5.36%-1.27M-230.07%-824.14K
Depreciation and amortization 1.94%105K2.81%403K8.08%107K6.19%103K-1.65%96K-1.02%97K-13.27%392K2.16%99K14.76%97K-40.42%97.61K
Other non cash items -43.24%42K193.42%71K112.86%18K289.47%74K251.67%75K-500.00%-96K-182.61%-76K-635.33%-140K-31.13%19K-12.77%21.33K
Change In working capital 17.44%4.32M351.41%1.77M-17.07%1.53M350.92%3.68M-17.03%-1.88M-136.68%-1.56M143.06%391K1,492.02%1.84M-33.50%815K-14.41%-1.61M
-Change in receivables ----46.67%506K-------------127.36%-209K144.46%345K96.09%-24K-----947.41%-253.39K
-Change in prepaid assets ----162.31%777K------------94.47%-65K-257.31%-1.25M176.77%1.32M----12.93%-1.41M
-Change in payables and accrued expense -----104.69%-78K-------------2,424.59%-1.42M808.20%1.66M195.02%329K-----51.39%133.85K
-Change in other current liabilities ----194.32%332K--------------0-254.39%-352K--0------0
-Change in other working capital ----1,441.18%228K------------204.44%137K91.24%-17K10,881.81%211K-----122.20%-75.5K
Cash from discontinued investing activities
Operating cash flow 19.87%-4.83M-21.81%-28.45M-3.12%-6.12M-41.98%-6.03M-22.38%-8.47M-25.22%-7.83M-4.11%-23.36M6.25%-5.94M-13.77%-4.25M-1.77%-6.92M
Investing cash flow
Cash flow from continuing investing activities -100.47%-32K199.11%20.22M99.99%-3K75,277.78%6.77M58,408.29%6.79M18,625.00%6.67M-7,033.92%-20.4M-27,114.97%-20.35M95.60%-9K-76.49%-11.65K
Net PPE purchase and sale ---32K85.45%-8K-400.00%-3K--0--086.11%-5K80.77%-55K101.34%1K95.60%-9K-76.49%-11.65K
Net investment purchase and sale --0199.42%20.23M--0--6.77M--6.79M--6.67M---20.35M---20.35M--0----
Cash from discontinued investing activities
Investing cash flow -100.47%-32K199.11%20.22M99.99%-3K75,277.78%6.77M58,408.29%6.79M18,625.00%6.67M-7,033.92%-20.4M-27,114.97%-20.35M95.60%-9K-76.49%-11.65K
Financing cash flow
Cash flow from continuing financing activities -100.81%-173K162.14%31.99M-70.32%1.74M1,727.38%21.29M2,262.59%3.69M5.13%5.27M-63.03%12.21M11,305.07%5.87M1,562.28%1.17M-98.04%156.27K
Net issuance payments of debt 21.57%-80K-6.82%-407K-1.96%-104K-6.25%-102K-6.76%-100K-13.48%-101K-4.10%-381K-26.71%-102K-27.53%-96K4.96%-93.67K
Net common stock issuance -100.74%-158K151.47%31.62M-75.37%1.47M1,591.36%21.33M1,279.95%3.45M5.52%5.37M-61.80%12.57M66,507.21%5.97M13,761.97%1.26M-96.90%249.94K
Proceeds from stock option exercised by employees 3.17%65K6,408.33%781K--375K--63K---------97.44%12K--0--0--0
Cash from discontinued financing activities
Financing cash flow -100.81%-173K162.14%31.99M-70.32%1.74M1,727.38%21.29M2,262.59%3.69M5.13%5.27M-63.03%12.21M11,305.07%5.87M1,562.28%1.17M-98.04%156.27K
Net cash flow
Beginning cash position 41.84%24.85M-71.73%11.67M23.54%39.98M-47.99%17.52M-59.80%15.87M-71.73%11.67M32.17%41.26M-32.70%32.36M-33.68%33.69M-21.60%39.48M
Current changes in cash -122.87%-5.04M175.33%23.77M78.52%-4.39M812.55%22.03M129.78%2.02M422.68%4.11M-406.46%-31.55M-215.95%-20.42M23.06%-3.09M-675.27%-6.77M
Effect of exchange rate changes -149.31%-215K-126.67%-522K-144.29%-684K-75.28%436K-137.70%-369K118.81%95K870.47%1.96M23.07%-280K35.15%1.76M232.27%978.82K
End cash Position -50.98%19.6M199.26%34.91M199.26%34.91M23.54%39.98M-48.00%17.52M-59.80%15.87M-71.73%11.67M-71.73%11.67M-32.70%32.36M-33.68%33.69M
Free cash flow 19.34%-4.86M-21.55%-28.46M-3.18%-6.13M-41.68%-6.03M-22.17%-8.47M-24.59%-7.83M-3.04%-23.41M7.36%-5.94M-8.09%-4.26M-1.84%-6.93M
Currency Unit CADCADCADCADCADCADCADCADCADCAD
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions --Unqualified Opinion--------Unqualified Opinion------
Trending US Stocks
Fed Rate Cut Beneficiaries Fed Rate Cut Beneficiaries

Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only. This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data. Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only. This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data.

Symbol Mini Chart % Chg
MicroStrategy
MSTR
+8.44%
NVIDIA
NVDA
+2.75%
Adobe
ADBE
+2.24%
Salesforce
CRM
+2.28%
Meritage Homes
MTH
+1.87%

Unlock the Full List

Investment Theme Top Gainers Yesterday
Top Gainers Yesterday
Intraday+0.14%